Global X MSCI China Health Care ETF
CHIH
New York Stock Exchange Arca- -
USD
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Global X MSCI China Health Care ETF (CHIH) is an exchange-traded fund that seeks to provide investment results corresponding generally to the price and yield performance, before fees and expenses, of the MSCI China Health Care 10/50 Index. The fund invests in large- and mid-capitalization segments of securities classified in the Health Care Sector per the Global Industry Classification Standard (GICS) within the MSCI China Index, incorporating China A shares, B shares, H shares, Red chips, P chips and foreign listings such as American Depository Receipts; its core offerings include exposure to pharmaceuticals (major, generic and other), biotechnology, medical specialties, hospital/nursing management, and related health care subsectors. CHIH targets investors seeking sector-specific access to China's health care industry, the second-largest economy by GDP, with a total expense ratio of 0.65%, semi-annual distributions and primary listing on NYSE Arca. Launched on December 7, 2018 by Global X Management Company LLC, headquartered at 605 Third Avenue, 43rd Floor, New York, NY, the ETF operated with net assets of approximately $6.58 million as of the latest available data. In a major strategic shift announced January 19, 2024, Global X Management Company LLC recommended the liquidation of CHIH and 18 other niche ETFs as part of an ongoing review of its product lineup to align with client needs; the fund ceased trading at the end of February 16, 2024, with liquidation completed around February 23, 2024, distributing cash proceeds equal to net asset value to remaining shareholders while the adviser bore associated fees. This closure reflected broader portfolio rationalization at Global X, a Mirae Asset Financial Group member managing over $40 billion in assets across thematic, income, commodity and international ETFs, amid low assets under management (less than 1% of total) for the affected funds. Prior to liquidation, CHIH provided targeted exposure to China's health care market without recent partnerships, funding rounds, acquisitions or new product launches noted in the last 1-2 years.